首页 > 市场调查报告书 > 製药

疼痛

北美医用大麻市场预测至 2028 年 - COVID-19 影响和区域分析 - 按产品类型、应用和配销通路

市场调查报告书

商品编码

1375112

北美医用大麻市场预测至 2028 年 - COVID-19 影响和区域分析 - 按产品类型、应用和配销通路

North America Medical Marijuana Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product Type, Application, and Distribution Channel

出版日期: 2023年08月22日 | 出版商:

The Insight Partners | 英文 127 Pages | 订单完成后即时交付

价格

简介目录图表

北美医用大麻市场预计将从2022年的71.7017亿美元成长到2028年的207.6041亿美元。预计2022年至2028年的复合年增长率为19.4%。

医用大麻产品的批准增加推动了北美医用大麻市场的成长

大麻的药用潜力吸引了各种研究人员和公司在医疗应用中使用大麻。例如，四氢大麻酚（THC）主要用于生产医药产品。美国食品药物管理局 (FDA) 已批准基于 THC 的药品，例如 Cesamet，其活性成分为 naboline，是一种具有类似 THC 结构的合成衍生产品。 Cesamet 用于治疗接受化疗的患者的噁心。当其他药物无法控制噁心和呕吐时，通常会开立 Cesamet。 FDA 也批准 Marinol 和 Syndros 在美国用于治疗用途。 Marinol 和 Syndros 含有活性成分屈大麻酚 - 一种合成的 9-THC，被认为是大麻的精神活性成分。 Marinol 和 Syndros 药物用于刺激消耗症候群患者的食慾，消耗症候群是爱滋病的适应症之一。同样，各种基于大麻的产品已获得批准或正在进行临床试验。例如，nabiximols (Sativex) 是在加拿大批准商业化的药物。 Nabiximols 是一种大麻萃取物，用于治疗与多发性硬化症相关的痉挛和神经性疼痛。它是由 THC 和其他大麻二酚 (CBD) 组合配製而成。 2020年2月，加拿大公司CanaQuest Medical Corp向加拿大卫生部申请核准Mentabinol的生产和商业化。 Mentabinol 是一种基于 THC 的产品，其批准申请已根据《大麻法》提交。 FDA 对上述大麻产品的批准增加正在推动医用大麻市场的发展。

北美医用大麻市场概况

北美医用大麻市场分为美国、加拿大和墨西哥。据估计，医用大麻市场在美国占有最大份额。医用大麻市场的成长可归因于探索创新治疗应用的研究和合作不断增加、人们对医用大麻的认识不断提高以及该地区主要参与者的存在。此外，该地区不断增长的老龄化人口也将有利于市场的成长。

北美医用大麻市场收入及 2028 年预测（百万美元）

北美医用大麻市场细分

北美医用大麻市场按产品类型、应用、配销通路和国家细分。

根据产品类型，北美医用大麻市场分为干燥形式和萃取物形式。 2022 年，萃取物形式在北美医用大麻市场中占据更大份额。

根据应用，北美医用大麻市场分为疼痛管理、妥瑞氏症、阿兹海默症、偏头痛、忧郁和焦虑、多发性硬化症、癌症等。 2022年，疼痛管理领域占据北美医用大麻市场的最大份额。

根据配销通路，北美医用大麻市场分为零售药房、电子商务等。 2022年，零售药局领域占据北美医用大麻市场的最大份额。

根据国家/地区，北美医用大麻市场分为美国、加拿大和墨西哥。 2022年，美国主导北美医用大麻市场。

阿芙莉亚公司； CanaQuest 医疗公司；顶篷 Growth 公司；翡翠健康治疗公司； GW 製药公司；马里坎公司； Organigram 控股公司；帕纳夏製药工业有限公司；菲娜控股公司；和 VIVO Cannabis Inc 是北美医用大麻市场的领先公司。

The medicinal potential of marijuana has attracted various researchers and companies to use marijuana in medical applications. For instance, tetrahydrocannabinol (THC) is predominantly used for producing medicinal products. The US Food and Drug Administration (FDA) has approved THC-based medicinal products such as Cesamet, which contains naboline as its active ingredient, is a synthetically derived product that has a structure like THC. Cesamet is prescribed for the treatment of nausea in patients receiving chemotherapy. Cesamet is generally prescribed when other medications cannot control nausea and vomiting. The FDA has also approved Marinol and Syndros for therapeutic uses in the US. Marinol and Syndros contain the active ingredient dronabinol-a synthetic 9-THC considered the psychoactive component of cannabis. Marinol and Syndros drugs are prescribed to stimulate appetite in patients with wasting syndrome, developed as one of the indications of AIDS. Similarly, various marijuana-based products have been approved or are in clinical trials. For instance, nabiximols (Sativex) is an approved drug commercialized in Canada. Nabiximols is a cannabis extract used to treat spasticity and neuropathic pain related to multiple sclerosis. It is formulated with a combination of THC and other cannabidiol (CBD). In February 2020, CanaQuest Medical Corp, a Canadian company, applied for the approval of the production and commercialization of Mentabinol to Health Canada. Mentabinol is a THC-based product, and its approval application has been filed under the Cannabis Act. The increase in approval of the above-mentioned marijuana-based products by the FDA is driving the medical marijuana market.

North America Medical Marijuana Market Overview

The North America medical marijuana market is segmented into the US, Canada, and Mexico. The medical marijuana market is estimated to have the largest share in the US. The growth of the medical marijuana market can be attributed to the increasing research and collaborations to explore innovative therapeutic applications, rising awareness regarding medical marijuana, and the presence of key players in the region. In addition, the growing aging population across the region will also favor the growth of the market.

North America Medical Marijuana Market Revenue and Forecast to 2028 (US$ Million)

North America Medical Marijuana Market Segmentation

The North America medical marijuana market is segmented into product type, application, distribution channel, and country.

Based on product type, the North America medical marijuana market is segmented into dried form and extract form. The extract form segment held a larger share of the North America medical marijuana market in 2022.

Based on application, the North America medical marijuana market is segmented into pain management, Tourette's, Alzheimer's disease, migraines, depression and anxiety, multiple sclerosis, cancer, and others. The pain management segment held the largest share of the North America medical marijuana market in 2022.

Based on distribution channel, the North America medical marijuana market is segmented into retail pharmacy, e-commerce, and others. The retail pharmacy segment held the largest share of the North America medical marijuana market in 2022.

Based on country, the North America medical marijuana market is segmented into the US, Canada, and Mexico. The US dominated the North America medical marijuana market in 2022.

Aphria, Inc.; CanaQuest Medical Corporation; Canopy Growth Corporation; Emerald Health Therapeutics Inc.; GW Pharmaceuticals; MARICANN INC.; Organigram Holdings Inc.; Panaxia Pharmaceutical Industries Ltd.; Phoena Holdings Inc.; and VIVO Cannabis Inc are the leading companies operating in the North America medical marijuana market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America medical marijuana market .
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in North America medical marijuana market , thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 North America Medical Marijuana Market - by Product
- 1.3.2 North America Medical Marijuana Market - by Application
- 1.3.3 North America Medical Marijuana Market - by Distribution Channel
- 1.3.4 North America Medical Marijuana Market - by Country

2. North America Medical Marijuana Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Medical Marijuana Market - Market Landscape

4.1 Overview
4.2 North America - PEST Analysis
4.3 Expert Opinion

5. North America Medical Marijuana Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Approvals of Medical Marijuana Products
- 5.1.2 Rising Acceptance of Medicinal Use of Marijuana in America
5.2 Market Restraints
- 5.2.1 Illegal Use of Cannabis as Street Drug and Misconceptions Regarding Marijuana
5.3 Market Opportunities
- 5.3.1 Increase in Job Opportunities in Marijuana Industry
5.4 Future Trends
- 5.4.1 Widespread Distribution of Medical Marijuana
5.5 Impact Analysis

6. Medical Marijuana Market - North America Analysis

6.1 North America Medical Marijuana Market Revenue Forecast and Analysis

7. North America Medical Marijuana Market Revenue and Forecast To 2028- by Product

7.1 Overview
7.2 North America Medical Marijuana Market Revenue Share, by Product (2021 and 2028)
7.3 Dried Form
- 7.3.1 Overview
- 7.3.2 Dried Form: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Extract Form
- 7.4.1 Overview
- 7.4.2 Extract Form: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)

8. North America Medical Marijuana Market Analysis - by Application

8.1 Overview
8.2 North America Medical Marijuana Market Revenue Share, by Application (2021 and 2028)
8.3 Pain Management
- 8.3.1 Overview
- 8.3.2 Pain Management: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Tourette's
- 8.4.1 Overview
- 8.4.2 Tourette's: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Alzheimer's Disease
- 8.5.1 Overview
- 8.5.2 Alzheimer's Disease: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Migraines
- 8.6.1 Overview
- 8.6.2 Migraines: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
8.7 Depression and Anxiety
- 8.7.1 Overview
- 8.7.2 Depression and Anxiety: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
8.8 Multiple Sclerosis
- 8.8.1 Overview
- 8.8.2 Multiple Sclerosis: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
8.9 Cancer
- 8.9.1 Overview
- 8.9.2 Cancer: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
8.10 Others
- 8.10.1 Overview
- 8.10.2 Others: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)

9. North America Medical Marijuana Market - by Distribution Channel

9.1 Overview
9.2 North America Medical Marijuana Market, by Distribution Channel (2021 and 2028)
9.3 Retail Pharmacy
- 9.3.1 Overview
- 9.3.2 Retail Pharmacy: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
9.4 E-Commerce
- 9.4.1 Overview
- 9.4.2 E-commerce: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Others
- 9.5.1 Overview
- 9.5.2 Others: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)

10. North America Medical Marijuana Market Revenue and Forecast to 2028 - Country Analysis

10.1 Overview
- 10.1.1 North America Medical Marijuana Market, by Country, 2021 & 2028 (%)
  - 10.1.1.1 US: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.1 US: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.2 US: Medical Marijuana Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.3 US: Medical Marijuana Market, by Application- Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.4 US: Medical Marijuana Market, Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
  - 10.1.1.2 Canada: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.1 Canada: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.2 Canada: Medical Marijuana Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.3 Canada: Medical Marijuana Market, by Application- Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.4 Canada: Medical Marijuana Market, Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
  - 10.1.1.3 Mexico: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.1 Mexico: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.2 Mexico: Medical Marijuana Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.3 Mexico: Medical Marijuana Market, by Application- Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.4 Mexico: Medical Marijuana Market, Distribution Channel - Revenue and Forecast to 2028 (US$ Million)

11. North America Medical Marijuana Market - Industry Landscape

11.1 Overview
11.2 Growth Strategies in the North America Medical Marijuana Market (%)
11.3 Organic Developments
- 11.3.1 Overview
11.4 Inorganic Developments
- 11.4.1 Overview

12. Company Profiles

12.1 VIVO Cannabis Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Panaxia Pharmaceutical Industries Ltd.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Phoena Holdings Inc.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Emerald Health Therapeutics Inc.
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 MARICANN INC.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Aphria, Inc.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Canopy Growth Corporation
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 CanaQuest Medical Corporation
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 GW Pharmaceuticals
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Organigram Holdings Inc.
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms for North America Medical Marijuana Market

简介目录图表

List Of Tables

Table 1. US: Medical Marijuana Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 2. US: Medical Marijuana Market, by Application - Revenue and Forecast to 2028 (US$ Million).
Table 3. US: Medical Marijuana Market, Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 4. Canada: Medical Marijuana Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 5. Canada: Medical Marijuana Market, by Application - Revenue and Forecast to 2028 (US$ Million).
Table 6. Canada: Medical Marijuana Market, Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 7. Mexico: Medical Marijuana Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 8. Mexico: Medical Marijuana Market, by Application - Revenue and Forecast to 2028 (US$ Million).
Table 9. Mexico: Medical Marijuana Market, Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 10. Organic Developments in the Medical Marijuana Market
Table 11. Inorganic Developments in the Medical Marijuana Market
Table 12. Glossary of Terms for North America Medical Marijuana Market

List Of Figures

Figure 1. North America Medical Marijuana Market Segmentation
Figure 2. North America Medical Marijuana Market, By Country
Figure 3. North America Medical Marijuana Market Overview
Figure 4. Extract Form Held Largest Share of Product Segment in Medical Marijuana Market
Figure 5. US to Show Remarkable Growth During Forecast Period
Figure 6. North America PEST Analysis
Figure 7. North America Medical Marijuana Market- Revenue Forecast and Analysis - 2020- 2028
Figure 8. North America Medical Marijuana Market Revenue Share, by Product (2021 and 2028)
Figure 9. Dried Form: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
Figure 10. Extract Form: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
Figure 11. North America Medical Marijuana Market Revenue Share, by Application (2021 and 2028)
Figure 12. Pain Management: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Tourette's: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Alzheimer's Disease: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
Figure 15. Migraines: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Depression and Anxiety: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. Multiple Sclerosis: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Cancer: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. Others: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. North America Medical Marijuana Market, by Distribution Channel (2021 and 2028)
Figure 21. Retail Pharmacy: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. E-commerce: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Others: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. North America Medical Marijuana Market, by Key Country - Revenue (2021) (US$ Million)
Figure 25. North America Medical Marijuana Market, by Country, 2021 & 2028 (%)
Figure 26. US: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Canada: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Mexico: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. Growth Strategies in the North America Medical Marijuana Market (%)